# Nectar Lifesciences Ltd (NECLIFE)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹12.21
Day Change: -0.49%
52W High: ₹38.88
52W Low: ₹12.6
Market Cap: ₹245 Cr

## Valuation
P/E: 0
P/B: 0.39
EPS: ₹-2.08
Book Value: ₹31.97
Dividend Yield: 0%

## Returns
1Y Return: -12.63%

## Profitability
ROE: 0%
ROCE: -7.55%
Debt/Equity: 0.64
Revenue Growth: 0%
Profit Growth: 82.9%
EBITDA Margin: -1.6%
Operating Margin: -5.41%

## About
Nectar Lifesciences Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Nectar Lifesciences Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Update On Slump Sale
- Announcement: Disclosure As Per Regulation 30 Of The Securities And Exchange Of Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
- BSE Filing: Update On Slump Sale

## Access
Current tier: anonymous
More history: Register free to see 13 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:03.547Z
Price History Updated: 2026-05-18T22:59:34.179Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:59:34.179Z
Quant Updated: 2026-05-18T22:59:34.179Z
Sentiment Updated: 2026-05-18T22:59:34.179Z
Financials Status: current
Financials Updated: 2026-05-18T23:02:06.821Z
Financials Last Attempt: 2026-05-18T23:02:06.821Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹1669.97 Cr
Operating Profit: ₹-88.83 Cr (OPM -5.32%)
Net Profit: ₹-113.68 Cr
Tax: ₹-47.85 Cr

## Annual P&L History
FY25: Rev ₹1669.97Cr | PAT ₹-113.68Cr | OPM -5.32%
FY24: Rev ₹1684.09Cr | PAT ₹5Cr | OPM 5.49%
FY23: Rev ₹1523.67Cr | PAT ₹-24.18Cr | OPM -0.34%

## Balance Sheet (FY25)
Total Assets: ₹2047.23 Cr
Total Liabilities: ₹1091.11 Cr
Borrowings: ₹582.02 Cr
Cash: ₹19.21 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Sanjiv  Goyal, Chairman & MD
- Sushil  Kapoor, CFO, Wholetime Director of Finance & Additional Director
- Sanjaymohan Singh Rawat, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/neclife
Disclaimer: For research and education only. Not investment advice.